Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Clinical trial NCT06950385 · RECRUITING

Trial details

NCT number: NCT06950385
Sponsor: Rapamycin Holdings Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Familial Adenomatous Polyposis (FAP)

Start date: 2025-07-18
Primary completion: 2030-07-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.